Current Drug Discovery Technologies This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Eco-friendly Strategy for the Synthesis of Spiro-benzimidazoquinazolinone and Spiro-benzothiazoloquinazolinone Derivatives using β-cyclodextrin as a Supramolecular Catalyst
CONCLUSION: The catalyst demonstrated remarkable effectiveness in producing the target compounds and conducting the reaction with different initial substances, resulting in excellent yields of the products, thereby confirming the broad applicability and versatility of this method.PMID:38151832 | DOI:10.2174/0115701638276530231220080041 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - December 28, 2023 Category: Drugs & Pharmacology Authors: Jyoti Baranwal Swastika Singh Smriti Kushwaha Archana Jyoti Source Type: research

Biological Activities of Zinc Oxide Nanoparticles Green Synthesized Using the Aqueous Extract of Dracocephalum kotschyi Boiss
CONCLUSION: The noteworthy point is that the inhibitory rate of synthesized zinc oxide nanoparticles is higher compared to broad-spectrum antibiotics, such as chloramphenicol (MIC values 15 mg/ml). Determining the therapeutic and toxic dose of this product for humans requires further investigation and clinical trials.PMID:38151833 | DOI:10.2174/0115701638284118231220074251 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - December 28, 2023 Category: Drugs & Pharmacology Authors: Foroogh Mirzania Iraj Salimikia Javad Ghasemian Yadegari Abdolrazagh Marzban Amirmasoud Firouzi Alireza Nazarzadeh Javid Aalaei Source Type: research

Design, Synthesis, Characterisation, and Evaluation of Substituted Quinolin-2-one Derivatives as Possible Anti-lung Cancer Agents
CONCLUSION: Compound VII a showed the highest MolDock score and was most potent against human lung cancer cell line Hop-62.PMID:38151847 | DOI:10.2174/0115701638258479231220051227 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - December 28, 2023 Category: Drugs & Pharmacology Authors: Riya Swar Prachita Gauns Dessai Shivalingrao MamleDesai Sachin Chandavarkar Soniya Phadte B Biradar Source Type: research

Articulate Chemotherapeutic Strategies for the Development of Effective Drugs against a Fatal Disease, Visceral Leishmaniasis
Curr Drug Discov Technol. 2023 Dec 21. doi: 10.2174/0115701638277134231218150109. Online ahead of print.ABSTRACTVisceral Leishmaniasis (VL) control relies mainly on chemotherapy in the absence of no effective vaccines. However, available anti-VL drugs are limited in number, having toxicity issues, adverse reactions, low efficacy, and resistance observed against antileishmanial. A significant decrease in efficacy (~tenfold increase in dosage and duration) was reported against the usual treatment with Pentavalent antimonials (the most recommended antileishmanial drug discovered 90 years ago). Amphotericin B is the second lin...
Source: Current Drug Discovery Technologies - December 23, 2023 Category: Drugs & Pharmacology Authors: Awanish Kumar Source Type: research

Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and in vitro Analysis
CONCLUSIONS: Overall, Kojic acid-mediated SDT as an MMP-9 inhibitor can be a promising adjuvant treatment for OSCC. The study highlights the potential of in silico approaches to evaluate therapeutic methods for cancer treatment.PMID:38073102 | DOI:10.2174/0115701638266082231124055825 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - December 11, 2023 Category: Drugs & Pharmacology Authors: Maryam Pourhajibagher Mojgan Alaeddini Shahroo Etemad-Moghadam Steven Parker Abbas Bahador Source Type: research